https://www.selleckchem.com/pr....oducts/enfortumab-ve
1 days vs. 5.1 days, p less then 0.05) and higher inpatient mortality (3.4% vs. 1.0%, p less then 0.05). A higher rate of VCF hospitalization along with an increasing trend was noted in AS as compared to RA and compared to the general population. Better screening approaches and treatment strategies for AS patients with VCF risk are urgently needed to reduce hospitalizations and related complications. Key Points • An increasing trend of VCF hospitalization was noted in AS, in contrast to a declining trend in RA and a
Like
Comment
Share
